瑞典北部早期类风湿关节炎起始队列中肺纤维化与遗传位点的关联
该研究纳入1466例早期RA患者的前瞻性起始队列,分析1184例可用DNA中13个已知遗传变异与肺纤维化(PF)的关系。PF患病率为5.6%,年发病率为5.0/1000(95%CI 3.80,6.54)。4个SNP与PF相关:MUC5B rs35705950、TOLLIP rs111521887、FAM13A rs2609255和TERT rs2736100;年龄较大和RF阳性增加风险,MTX治疗与较低风险相关。
要点
- 早期RA队列中PF患病率5.6%,年发病率5.0/1000(95%CI 3.80,6.54)。
- MUC5B rs35705950与PF关联最强(OR 2.5,95%CI 1.5,4.0,adj P=0.00016)。
- 年龄较大和RF阳性增加PF风险,MTX治疗与较低风险相关。
核心结论
- 早期RA起始队列中PF的发生与12个ILD风险基因中的4个相关。
- 除诊断时年龄和RF阳性外,RA相关因素对PF发展的重要性有限。
研究设计与样本
- 前瞻性起始队列研究,连续纳入1466例早期RA患者,随访至死亡或2016年12月31日。
主要发现
- PF患病率为5.6%,年发病率为5.0/1000(95%CI 3.80,6.54)。
- rs35705950(MUC5B)与PF相关:OR 2.5(95%CI 1.5,4.0),调整P=0.00016,q=0.0021。
- rs111521887(TOLLIP)与PF相关:OR 1.9(95%CI 1.3,2.8),调整P=0.0014,q=0.0092。
- rs2609255(FAM13A)与PF相关:OR 1.7(95%CI 1.1,2.5),调整P=0.013,q=0.055。
- rs2736100(TERT)与PF相关:OR 1.5(95%CI 1.0,2.2),调整P=0.046,q=0.15。
关键数值与推荐
- 13个已知遗传变异中4个SNP与PF相关:MUC5B rs35705950、TOLLIP rs111521887、FAM13A rs2609255、TERT rs2736100。
- 年龄较大和RF阳性与PF风险增加相关,MTX治疗与PF风险降低相关。
临床怎么用
- 对早期RA患者可关注MUC5B、TOLLIP、FAM13A、TERT相关SNP以识别PF高风险者。
- 年龄较大和RF阳性的早期RA患者应警惕PF发生。
- MTX治疗可能与降低PF风险相关,但需结合临床综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pulmonary manifestations in RA are common comorbidities. Interstitial lung disease (ILD), both idiopathic and in RA, has been associated with several genetic variants. We assessed pulmonary fibrosis (PF) in an inception cohort of RA patients in relation to genetic variants and disease-related factors. METHODS: A total of 1466 early RA patients were consecutively included and followed prospectively from the index date until death or 31 December 2016. Clinical and laboratory data and treatment were continuously registered according to the Swedish Rheumatology Quality Register. DNA was available from 1184 patients and 571 151 genome-wide single-nucleotide polymorphisms (SNPs) were analysed. Thirteen identified genetic variants were extracted. At follow-up, the patients answered a questionnaire regarding disease progression and lung involvement that was validated by reviewing medical records and analysing radiological examinations. RESULTS: The prevalence of PF was 5.6% and the annualized incidence rate was 5.0/1000 (95% CI 3.80, 6.54). Four SNPs were associated with PF in RA: rs35705950 [MUC5B; OR 2.5 (95% CI 1.5, 4.0), adjusted P-value = 0.00016, q-value = 0.0021]; rs111521887 [TOLLIP; OR 1.9 (95% CI 1.3, 2.8), adjusted P-value = 0.0014, q-value = 0.0092]; rs2609255 [FAM13A; OR 1.7 (95% CI 1.1, 2.5), adjusted P-value = 0.013, q-value = 0.055] and rs2736100 [TERT; OR 1.5 (95% CI 1.0, 2.2), adjusted P-value = 0.046, q-value = 0.15]. Older age and RF positivity were associated with increased risk, while MTX treatment was associated with a lower risk of PF. CONCLUSIONS: Development of PF in an inception cohort of RA patients was associated with 4 of 12 ILD risk genes. RA-related factors except for age at diagnosis and RF positivity were of limited importance in PF development.
引用
- Jönsson E, Ljung L, Norrman E, et al. Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from northern Sweden. Rheumatology (Oxford). 2022. PMID: 33993221. doi:10.1093/rheumatology/keab441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。